{
  "id": 7929383,
  "title": "DaVita jumps 10% as AI strategy’s healthcare pick rides stronger guidance",
  "url": "https://urgent.news/2026/09/17/davita-jumps-10-as-ai-strategys-healthcare-pick-rides-stronger",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-17T02:19:36.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/davita-jumps-10-as-ai-strategys-healthcare-pick-rides-stronger-guidance-4904761"
  },
  "original_language": "en",
  "account": "DaVita, a healthcare company, has experienced a remarkable 10% surge in its stock price following stronger-than-expected guidance for the year 2026. The company's earnings guidance of $14.10 to $15.20 per share surpassed the consensus estimate of $14.57 per share, indicating a favorable outlook for investors. This positive development has caught the attention of Investing.com's AI-powered Strategies models, which had already identified DaVita as a strong performer within the Healthcare Heroes strategy. The stock's price has climbed from $189.32 to $193.86, marking a 10.06% increase since the beginning of the month. With a market capitalization of $12.41 billion, DaVita's valuation is considered attractive by analysts, who assign a Moderate Buy rating and estimate a potential 23% upside from the current price.",
  "summary": null,
  "key_points": [
    "DaVita's stock jumps 10% on stronger guidance for 2026",
    "Earnings guidance of $14.10-$15.20 per share beats $14.57 estimate",
    "AI strategy's Healthcare Heroes picks DaVita as strong performer"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}